GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » Earnings per Share (Diluted)

Vicplas International (SGX:569) Earnings per Share (Diluted) : S$0.00 (TTM As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Vicplas International Earnings per Share (Diluted)?

Vicplas International's Earnings per Share (Diluted) for the six months ended in Jan. 2024 was S$0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was S$0.00.

Vicplas International's EPS (Basic) for the six months ended in Jan. 2024 was S$0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was S$0.00.

Vicplas International's EPS without NRI for the six months ended in Jan. 2024 was S$0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was S$0.00.

During the past 12 months, Vicplas International's average EPS without NRIGrowth Rate was -75.00% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 4.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 10.80% per year.

During the past 13 years, Vicplas International's highest 3-Year average EPS without NRI Growth Rate was 39.50% per year. The lowest was -16.40% per year. And the median was -1.05% per year.


Vicplas International Earnings per Share (Diluted) Historical Data

The historical data trend for Vicplas International's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International Earnings per Share (Diluted) Chart

Vicplas International Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.02 0.02 0.01

Vicplas International Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 - -

Competitive Comparison of Vicplas International's Earnings per Share (Diluted)

For the Medical Devices subindustry, Vicplas International's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicplas International's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vicplas International's PE Ratio distribution charts can be found below:

* The bar in red indicates where Vicplas International's PE Ratio falls into.



Vicplas International Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Vicplas International's Earnings Per Share (Diluted) for the fiscal year that ended in Jul. 2023 is calculated as

Diluted Earnings Per Share (A: Jul. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(4.238-0)/516.910
=0.01

Vicplas International's Earnings Per Share (Diluted) for the quarter that ended in Jan. 2024 is calculated as

Diluted Earnings Per Share (Q: Jan. 2024 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.224-0)/513.709
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Vicplas International  (SGX:569) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Vicplas International Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Vicplas International's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicplas International (SGX:569) Business Description

Traded in Other Exchanges
N/A
Address
35 Joo Koon Circle, Singapore, SGP, 629110
Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines